HS-10515

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameHS-10515
Drug Alias NameHS-10515HS10515
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN inhibitors
TargetsBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Therapy Area/IndicationsMicrosatellite instability-high cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Hansoh Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Hansoh Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsMicrosatellite instability-high cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A